Christophe Dubois
About Christophe Dubois
Christophe Dubois serves as the Head of the Master Degree 'Biologie Santé' at Aix Marseille University and leads a research team focused on thrombosis and cancer. He completed his PhD in Biology/Hemostasis at Université de la Méditerranée and has prior experience working at Roche Pharmaceuticals.
Work at Aix-Marseille University
Christophe Dubois serves as the Head of the Master Degree program in 'Biologie-Santé' at Aix-Marseille University. He has held this position since 2017, contributing to the academic and administrative leadership of the program. His role involves overseeing the curriculum, coordinating faculty, and ensuring the program meets educational standards. Additionally, he has been a team leader in the Thrombosis and Cancer research group at Aix-Marseille University since 2012, focusing on advancing research in these critical areas.
Education and Expertise
Christophe Dubois completed his PhD in Biology with a specialization in Hemostasis at Université de la Méditerranée (Aix-Marseille II) from 1999 to 2003. His academic background provides a strong foundation in biological sciences, particularly in the mechanisms of blood coagulation and its implications in health and disease. This expertise informs his teaching and research activities at Aix-Marseille University.
Background
Before his current roles, Christophe Dubois worked at Roche Pharmaceuticals from 1999 to 2003 during his PhD studies. This experience in the pharmaceutical industry contributed to his understanding of the application of biological research in clinical settings. His transition to academia allowed him to focus on teaching and research, particularly in the fields of thrombosis and cancer.
Achievements
Christophe Dubois has been actively involved in research related to thrombosis and cancer at Aix-Marseille University. His leadership in the Master Degree program and his research initiatives reflect his commitment to advancing knowledge in these areas. His work contributes to the broader scientific community's understanding of the interplay between thrombosis and cancer, although specific achievements in terms of publications or projects are not detailed.